Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03839745 · ClinicalTrials.gov registry record · NA

Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power

A NA study of Nicotine Dependence and Cardiovascular Risk Factor, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
16
Enrollment target
2
Study locations

NCT03839745 is a NA study of Nicotine Dependence and Cardiovascular Risk Factor that has completed, run by University of California, San Francisco. The registered enrollment target is 16 participants, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03839745, a NA study of Nicotine Dependence and Cardiovascular Risk Factor, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
2
Study locations

Study Summary

This study will examine the short-term cardiovascular (CV) effects of e-cigarette device power in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim is to determine the impact of e-cigarette power on nicotine pharmacology, systemic exposure to toxic volatile organic compounds (VOCs), and short-term cardiovascular effects.

Interventions

  • OTHER Electronic Cigarette

Study Locations (2)

California

  • Zuckerberg San Francisco General Hospital - San Francisco
  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2019-03-26
Est. Completion 2021-12-31
Phase NA

What the Registry Record Tells You About NCT03839745

The ClinicalTrials.gov registry entry for NCT03839745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (91% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Electronic Cigarette is the first listed.

NCT03839745 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03839745 about?

NCT03839745 is a clinical study titled "Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power". This study will examine the short-term cardiovascular (CV) effects of e-cigarette device power in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim is to determine the impact of e-cigarette power on nicotine pharmacolog...

What is the current status of trial NCT03839745?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-03-26. Estimated completion is 2021-12-31.

What conditions does trial NCT03839745 study?

This clinical trial studies the following conditions: Nicotine Dependence, Cardiovascular Risk Factor.

What interventions are being tested in trial NCT03839745?

The interventions under investigation include: Electronic Cigarette (OTHER).

Who is sponsoring clinical trial NCT03839745?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03839745 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.